Launched in 2019, the 5-year Vaccine Against Canine Cancer Study (VACCS) successfully enrolled 800 dogs in less than three years, allowing for a fully enrolled double-blind study of the Calviri vaccine. During clinical trials, scientists found that the vaccine was doing two things: as expected, it’s protecting patients from cancer, but surprisingly, it’s also protecting them from non-cancer diseases.

Read More